Results 31 to 40 of about 4,731,201 (386)

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

European Heart Journal-Cardiovascular Imaging, 2015
The rapid technological developments of the past decade and the changes in echocardiographic practice brought about by these developments have resulted in the need for updated recommendations to the previously published guidelines for cardiac chamber ...
R. Lang, L. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande, F. Flachskampf, E. Foster, S. Goldstein, T. Kuznetsova, P. Lancellotti, D. Muraru, M. Picard, E. Rietzschel, L. Rudski, K. Spencer, W. Tsang, J. Voigt   +17 more
semanticscholar   +1 more source

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

Circulation, 2023
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality.
C. Ndumele, J. Rangaswami, Sheryl L Chow, I. Neeland, Katherine Tuttle, Sadiya S. Khan, J. Coresh, Roy O Mathew, C. Baker-Smith, M. Carnethon, Jean-Pierre Després, Jennifer E Ho, Joshua J Joseph, Walter N Kernan, Amit Khera, Mikhail N. Kosiborod, Carolyn L. Lekavich, Eldrin F. Lewis, Kevin B Lo, Bige Ozkan, Latha P. Palaniappan, Sonali S Patel, Michael J. Pencina, Tiffany Powell-wiley, Laurence S Sperling, Salim S. Virani, Jackson T Wright, Radhika Rajgopal Singh, Mitchell S. V. Elkind   +28 more
semanticscholar   +1 more source

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy

European Cardiology Review, 2019
Imaging plays a pivotal role in the diagnostic and prognostic assessment of cardiovascular diseases. During the past two decades, there has been an expansion of the available imaging techniques, some of which are now part of routine clinical practice.
Cattaneo M., Froio A., Gallino A.
openaire   +5 more sources

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events

Journal of the American Heart Association, 2023
Background Although there is research on the impact of social determinants of health (SDOHs) on cardiovascular health, most existing evidence is based on individual SDOH components. We evaluated the impact of cumulative SDOH burden on cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular disease ...
Isaac Acquah, Kobina Hagan, Zulqarnain Javed, Mohamad B. Taha, Javier Valero‐Elizondo, Nwabunie Nwana, Tamer Yahya, Garima Sharma, Martha Gulati, Aziz Hammoud, Michael D. Shapiro, Ron Blankstein, Michael J. Blaha, Miguel Cainzos‐Achirica, Khurram Nasir   +14 more
openaire   +3 more sources

Hemodynamic variables in piglets anesthetized with isoflurane or propofol, kept under spontaneous ventilation and FIO2 of 0.5 [PDF]

Arquivo Brasileiro de Medicina Veterinária e Zootecnia
This study aimed to evaluate comparatively the effects of propofol or isoflurane on hemodynamic variables in piglets that received inspired oxygen fraction (FIO2) of 0.5 under spontaneous ventilation.
C.K. Ido, P.E.S. Silva, H.R.A. Silva, E.G.F. Biteli, R.L. Carneiro, P.C.F. Lopes, A.P. Gering, N. Nunes   +7 more
doaj   +2 more sources

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review

Frontiers in Endocrinology, 2022
ObjectiveWe assessed the effects of sodium glucose cotransporter-2 inhibitors (SGLT2is) versus dipeptidyl peptidase-4 inhibitors (DPP4is) in a large real-world Asian cohort with type 2 diabetes (T2D) and performed a systematic review with integrating the
Chun-Ting Yang, Zi-Yang Peng, Yi-Chi Chen, Huang-Tz Ou, Huang-Tz Ou, Shihchen Kuo   +5 more
doaj   +1 more source

C-peptide: a predictor of cardiovascular mortality in subjects with established atherosclerotic disease [PDF]

, 2017
Aim: Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past ...
Ballanti, Marta, Cardellini, Marina, Cardolini, Iris, Davato, Francesca, Farcomeni, Alessio, Federici, Massimo, Grappasonni, Giulia, Guglielmi, Valeria, Ippoliti, Arnaldo, Menghini, Rossella, Morelli, Monica, Pecchioli, Chiara, Porzio, Ottavia, Rizza, Stefano   +13 more
core   +1 more source

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

New England Journal of Medicine, 2020
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.
M. Packer, S. Anker, J. Butler, G. Filippatos, S. Pocock, P. Carson, J. Januzzi, S. Verma, H. Tsutsui, M. Brueckmann, W. Jamal, K. Kimura, J. Schnee, C. Zeller, D. Cotton, E. Bocchi, M. Böhm, D. Choi, V. Chopra, E. Chuquiure, N. Giannetti, S. Janssens, Jian Zhang, J. G. González Juanatey, S. Kaul, H. Brunner-la Rocca, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, N. Sattar, M. Senni, M. Séronde, J. Špinar, I. Squire, S. Taddei, C. Wanner, F. Zannad   +38 more
semanticscholar   +1 more source

Report on cardiovascular health and diseases in China 2021: an updated summary.

Journal of Geriatric Cardiology, 2023
In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to CVD.
The Writing Committee Of The Report On Cardiovascular In China, Sheng-shou Hu   +1 more
semanticscholar   +1 more source

The Vascular-Dependent and -Independent Actions of Calcitonin Gene-Related Peptide in Cardiovascular Disease

Frontiers in Physiology, 2022
The treatment of hypertension and heart failure remains a major challenge to healthcare providers. Despite therapeutic advances, heart failure affects more than 26 million people worldwide and is increasing in prevalence due to an ageing population ...
Fulye Argunhan, Susan D. Brain
doaj   +1 more source